Cardiac Fibrosis: Mechanistic Discoveries Linked to SGLT2 InhibitorsFilip Rolski, Michał Ma̧czewski|Pharmaceuticals|2025Cited by 21
Dapagliflozin, An SGLT2 Inhibitor, Improves Endothelial Cell Energy Metabolism Through Enhanced Mitochondrial RespirationIga Walczak, Barbara Kutryb-Zając, Marcin Hellmann et al.|Cellular Physiology and Biochemistry|2025Cited by 6
Special focus on the mitochondria in endothelial cells: A novel therapeutic target for gliflozins?Maria Tarnawska, Barbara Kutryb-Zając, Aleksandra Paterek et al.|Biomedicine & Pharmacotherapy|2025Cited by 3
Myo‐inositol trispyrophosphate prevents right ventricular failure and improves survival in monocrotaline‐induced pulmonary hypertension in the ratMarta Oknińska, Michał Ma̧czewski, Aleksandra Paterek et al.|British Journal of Pharmacology|2024Cited by 2
Impaired coronary flow reserve by hyperviscosity in a mouse model of non-light chain multiple myeloma: a mechanism of coronary flow impairment at the capillary levelAleksandra Paterek, Michał Ma̧czewski, Tomasz Skirecki et al.|Cardiovascular Research|2025Cited by 1